Position in CELC
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$12,174,625
+$1,443,756 QoQ
Shares Held
116,370
+23.8% QoQ
Ownership
0.238%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 274 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,844,643,771 across 310 Biotechnology names. CELC ranks #58 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in CELC
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,174,625 | 116,370 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $10,730,869 | 94,015 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $8,839,255 | 88,623 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $4,190,058 | 84,819 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $891,765 | 66,799 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $695,223 | 68,766 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $839,395 | 64,125 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $794,658 | 53,297 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,085,273 | 66,256 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,003,211 | 46,445 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $764,283 | 52,456 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $431,325 | 47,191 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $518,156 | 47,191 | Shares | Defined | 2023-08-03 | |
| 2022-03-31 | $265,156 | 28,359 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $363,766 | 27,579 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $390,204 | 21,678 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $391,392 | 16,308 | Shares | Defined | 2021-08-11 | |
| 2020-03-31 | $100,157 | 15,409 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||